Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.08 -0.07 (-6.09%)
At close: Oct 22, 2026 · 4:00 PM EDT

Chemomab Therapeutics (CMMB) Interest Expenses (2011 - 2019)

Updated

Chemomab Therapeutics' Interest Expenses was -$431,000 in Q4 2023, compared with -$380,000 a year earlier.

Analysis

Chemomab Therapeutics (CMMB) Interest Expenses (2011 - 2019) Analysis & Trends

For FY2023, Interest Expenses at Chemomab Therapeutics came in at -$1.24 million.

  • In earlier years, Interest Expenses was -$353,000 in FY2022, $111,000 in FY2021, $6,000 in FY2020 (-33.3%) and $9,000 in FY2019 (-99.4%).
  • The Q4 2023 figure marks the lowest quarterly Interest Expenses since Q2 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 217.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 435.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 247.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Chemomab Therapeutics 6.82 Mn -28.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -22.55 Mn
Sep 30, 2019 25.04 Mn
Jun 30, 2019 -2.75 Mn
Mar 31, 2019 12.87 Mn
Dec 31, 2018 -412,000.00
Sep 30, 2018 132,000.00
Jun 30, 2018 1.61 Mn
Mar 31, 2018 76,000.00
Dec 31, 2012 -971,505.13
Sep 30, 2012 33,202.48
Jun 30, 2012 1.34 Mn
Dec 31, 2011 998,370.41
Sep 30, 2011 127,507.76
Jun 30, 2011 -493,284.49
API Access

Chemomab Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=CMMB&period=max&api_key=YOUR_API_KEY